Motilal Oswal is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 915 in its research report dated March 06, 2017.

Top trading ideas by SP Tulsian

In an interview to CNBC-TV18 SP Tulsian, sptulsian.com shared his reading and outlook on the market and also gave recommendations on various stocks.

Buy Aurobindo Pharma; target of Rs 1110: Centrum

Centrum is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1110 in its research report dated February 21, 2017.

Buy Aurobindo Pharma; target of Rs 801: Geojit Research

Geojit Research is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 801 in its research report dated February 23, 2017.

Buy Aurobindo Pharma; target of Rs 800: Axis Direct

Axis Direct is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 800 in its research report dated February 16, 2017.

Buy Aurobindo Pharma; target of Rs 1110: Centrum

Centrum is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1110 in its research report dated February 10, 2017.

Buy Aurobindo Pharma; target of Rs 917: Khambatta Securities

Khambatta Securities is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 917 in its research report dated February 13, 2017.

Buy Aurobindo Pharma; target of Rs 1050: Motilal Oswal

Motilal Oswal is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1050 in its research report dated February 10, 2017.

Buy Aurobindo Pharma; target of Rs 965: ICICI Direct

ICICI Direct is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 965 in its research report dated February 13, 2017.

Buy Aurobindo Pharma; target of Rs 1100: ICICI Direct

ICICI Direct is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1100 in its research report dated January 11, 2017.

Nifty on Cloud Nine! 9 stocks with a high margin of safety

With Nifty a whisker away from its lifetime high and valuation touching 21X FY17P and 18X FY18P earnings, the Street looks cautious. Is it time to take money off the table?

Buy Aurobindo Pharma; target of Rs 1050: Motilal Oswal

Motilal Oswal is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1050 in its research report dated December 16, 2016.

Buy Aurobindo Pharma; target of Rs 1050: Motilal Oswal

Motilal Oswal is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1050 in its research report dated December 16, 2016.

Buy Aurobindo Pharma; target of Rs 1060: Centrum

Centrum is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1060 in its research report dated November 15, 2016.

Buy Aurobindo Pharma; target of Rs 970: Axis Direct

Axis Direct is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 970 in its research report dated October 07, 2016.

Buy Aurobindo Pharma; target of Rs 970: Axis Direct

Axis Direct is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 970 in its research report dated August 25, 2016.

Buy Aurobindo Pharma; target of Rs 1000: Religare

Religare is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1000 in its research report dated August 24, 2016.

Buy Aurobindo Pharma; target of Rs 990: ICICI Direct

ICICI Direct is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 990 in its research report dated June 01, 2016.

Buy Aurobindo Pharma; target of Rs 943: Prabhudas Lilladher

Prabhudas Lilladher is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 943 in its research report dated Februrary 10, 2016.

Buy Aurobindo Pharma; target of Rs 849: EIS

EIS is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 849 in its research report dated February 11, 2016.

Buy Aurobindo Pharma;target of Rs 940: Axis Securities

Axis Securities is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 940 in its research report dated February 11, 2016.

Buy Aurobindo Pharma; target of Rs 905: Emkay

Emkay is bullish on Aurobindo Pharma and has recommended buy rating on the stock with a target price of Rs 905 in its research report dated February 11, 2016.

Buy Aurobindo Pharma; target of Rs 935: Religare

Religare is bullish on Aurobindo Pharma and has recommended buy rating on the stock with a target price of Rs 935 in its research report dated December 17, 2015.

Buy Aurobindo Pharma; target of Rs 990: ICICIdirect

ICICIdirect is bullish on Aurobindo Pharma and has recommended buy rating on the stock with a target of Rs 990, in its November 10, 2015. research report.

Accumulate Aurobindo Pharma; target of Rs 824: Angel

Angel Broking is bullish on Aurobindo Pharma and has recommended accumulate rating on the stock with a target of Rs 824 in its research report dated August 18, 2015.